Global markets displayed strong bullish momentum on June 21, 2026, with US markets showing robust gains as the S&P 500 rose 1.44% and Nasdaq surged 2.74%. However, recent developments have introduced new uncertainties into the market landscape. The dollar index surged to a 13-month high of 101.1 following the Federal Reserve's hawkish policy pivot, with nine of 18 officials penciling in at least one rate hike in 2026, with six projecting two separate 25-basis-point hikes. This shift has created a complex backdrop for commodity markets, with traders now seeing an 89 percent chance of a December rate hike, up sharply from 61 percent before the Fed decision. The hawkish stance has particularly impacted precious metals, with gold and silver posting a third consecutive weekly loss despite earlier optimism around the US-Iran framework agreement.
Nifty Pharma appears to be transitioning into a constructive phase, exhibiting early signs of a bullish turnaround supported by both technical indicators and derivatives data. As reported by The Financial Express, the price action on the weekly chart reveals the formation of a pinbar doji, a pattern that typically signifies rejection of lower levels and suggests that buyers are stepping in aggressively during dips. This behaviour reflects strengthening demand dynamics and hints at a gradual shift in sentiment from bearish to bullish. On the daily timeframe, the index is steadily approaching a breakout above its downward-sloping trendline resistance, a key level that has capped upside attempts in recent sessions.
From a derivatives perspective, the setup further reinforces the constructive outlook. According to The Financial Express, a significant portion of the segment, nearly 90% of stock futures, witnessed either long buildup or short covering during the latest trading session, suggesting that traders are increasingly positioning for an upside move. On a broader weekly basis, about half of the stocks in the index registered short covering, highlighting broad-based participation rather than isolated strength. At the stock level, multiple heavyweights are displaying encouraging signs of accumulation and relative outperformance, with names such as Biocon, Sun Pharmaceutical Industries, Aurobindo Pharma, Laurus Labs, and Lupin likely to act as key drivers supporting the index's upside potential. The 79.4% of Nifty 500 constituents closed above their respective 10-day SMA on Friday, indicating broad-based market strength.
In contrast to the pharma sector's bullish outlook, metal stocks are experiencing significant weakness with Vedanta tumbling up to 7% in Tuesday's trade following a massive block deal, while National Aluminium (NALCO), Hindustan Zinc, Hindalco, Jindal Steel and NMDC declined 3-5% each. According to Business Standard, metal stocks are among the top losers on the BSE and NSE so far in June, with the Nifty Metal index shedding over 4% even as the Nifty 50 gained 2.5%. The recent underperformance can be attributed to profit-taking after the Nifty Metal index had surged over 20% this calendar year, while the Nifty 50 declined almost 10%. Jatin Gedia, VP-Technical Research at Teji Mandi, believes the Metal index is undergoing a consolidation phase after stellar outperformance, with the uptrend remaining intact and the index quoting above the 20-week average of 12,470.
From a technical perspective, individual metal stocks are showing mixed signals with specific support and resistance levels identified. Vedanta is currently trading below its support zone of ₹300-₹290, coinciding with the 40-day exponential moving average and 50% Fibonacci retracement level of ₹291, with a sustained trade below ₹290 potentially leading to a drop toward ₹275. Hindalco shows support in the ₹994-₹965 range with resistance around ₹1,070-₹1,090 levels, while National Aluminium has been consolidating between ₹360-₹440 since the beginning of the calendar year. The technical outlook suggests that Nifty Metal is expected to broadly consolidate between 12,500-13,500 levels, with the previous resistance zone of 12,500-12,470 now acting as support. The dollar strength and hawkish Fed stance are creating headwinds for commodity markets, with precious metals facing continued downward pressure despite the consolidation phase expected to continue.
